Related Experiment Video
Updated: Aug 23, 2026
Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
Published on: March 6, 2014
Magnetic Resonance Imaging-Based Internal Mammary Node Response After Neoadjuvant Therapy to Guide Postoperative
Yushuo Peng1, Siyuan Zhang1, Jian Tie1
1Department of Radiation Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
Purpose:
A radiation therapy boost to the internal mammary nodes (IMNs) is often recommended for patients with breast cancer and clinically positive IMNs at baseline, but it may increase treatment-related toxicity. Given the widespread use of neoadjuvant therapy (NAT), we investigated whether magnetic resonance imaging-assessed IMN clinical complete response (icCR) after NAT could inform response-adapted IMN boost strategies.
Methods And Materials:
This retrospective study included 208 patients with clinically positive IMNs at baseline. The association between an IMN boost and outcomes was evaluated in the overall cohort and in subgroups defined by magnetic resonance imaging-assessed post-NAT icCR status. Inverse probability of treatment weighting (IPTW) was used to improve balance in selected measured baseline characteristics and reduce observed treatment selection bias. Effect modification by icCR status was assessed using IPTW-weighted Cox proportional hazards models with an interaction term.
Results:
At a median follow-up of 36 months, an IMN boost was not associated with a significant improvement in disease-free survival (DFS) in the overall cohort (IPTW-adjusted hazard ratio [HR], 0.66; 95% CI, 0.32-1.39; P = .277). However, a significant interaction was observed between IMN boost and icCR status (P for interaction = .042). In subgroup analyses, an IMN boost was associated with improved DFS in patients without icCR (IPTW-adjusted HR, 0.36; 95% CI, 0.14-0.93; P = .034), whereas no significant improvement in DFS was observed among patients who achieved icCR (IPTW-adjusted HR, 1.13; 95% CI, 0.47-2.74; P = .781).
Conclusions:
In this study, patients without icCR showed improved DFS with an IMN boost, whereas those who achieved icCR showed no clear benefit. These findings support further evaluation of post-NAT icCR status as a potential indicator for selecting response-adapted postoperative IMN radiation therapy boost and warrant prospective validation.
More Related Videos
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024